These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23062076)

  • 1. A fresh look at paralytics in the critically ill: real promise and real concern.
    Price D; Kenyon NJ; Stollenwerk N
    Ann Intensive Care; 2012 Oct; 2(1):43. PubMed ID: 23062076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paralytics in critical care: not always the bad guy.
    Forel JM; Roch A; Papazian L
    Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Lyu T; Lee YS; Dhanvijay S; Freebairn R
    Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome.
    Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM
    Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.
    Iavarone IG; Al-Husinat L; Vélez-Páez JL; Robba C; Silva PL; Rocco PRM; Battaglini D
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
    Shao S; Kang H; Tong Z
    BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of paralytics in patients with acute respiratory distress syndrome.
    Hraiech S; Dizier S; Papazian L
    Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
    Torbic H; Krishnan S; Harnegie MP; Duggal A
    Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular blocking agents for acute respiratory distress syndrome.
    Torbic H; Duggal A
    J Crit Care; 2019 Feb; 49():179-184. PubMed ID: 30396789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Neuromuscular Blockers in Patients with ARDS in ICU: A Retrospective Study Based on the MIMIC-III Database.
    Pan X; Liu J; Zhang S; Huang S; Chen L; Shen X; Chen D
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the use of neuromuscular blocking agents on acute respiratory distress syndrome outcomes: A systematic review.
    Paramore S
    J Am Assoc Nurse Pract; 2018 Jun; 30(6):327-332. PubMed ID: 29878965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blockade management in the critically Ill patient.
    Renew JR; Ratzlaff R; Hernandez-Torres V; Brull SJ; Prielipp RC
    J Intensive Care; 2020; 8():37. PubMed ID: 32483489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive Care Nurses' Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure.
    Frazee EN; Personett HA; Bauer SR; Dzierba AL; Stollings JL; Ryder LP; Elmer JL; Caples SM; Daniels CE
    Am J Crit Care; 2015 Sep; 24(5):431-9. PubMed ID: 26330436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.